Cargando…
Replacing Alteplase with Tenecteplase: Is the Time Ripe?
Thrombolysis for acute ischemic stroke has predominantly been with alteplase for over a quarter of a century. In recent years, with trials showing evidence of higher rates of successful reperfusion, similar safety profile and efficacy of tenecteplase (TNK) as compared to alteplase, TNK has now emerg...
Autores principales: | Singh, Nishita, Menon, Bijoy K., Dmytriw, Adam A., Regenhardt, Robert W., Hirsch, Joshua A., Ganesh, Aravind |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Stroke Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911848/ https://www.ncbi.nlm.nih.gov/pubmed/36746381 http://dx.doi.org/10.5853/jos.2022.02880 |
Ejemplares similares
-
Tenecteplase or Alteplase: What Is the Thrombolytic Agent of the Future?
por: Mahmood, Ammad, et al.
Publicado: (2022) -
Is tenecteplase ready to replace alteplase to treat acute ischaemic stroke? The knowns and unknowns
por: Dong, Yi, et al.
Publicado: (2021) -
Switching to Tenecteplase from Alteplase for Ischemic Stroke: Is it the Time
for Universal Adoption?
por: Kharel, Sanjeev, et al.
Publicado: (2022) -
Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review
por: Zhu, Annie, et al.
Publicado: (2022) -
Cost-effectiveness of tenecteplase versus alteplase for acute ischemic stroke
por: Nguyen, Chi Phuong, et al.
Publicado: (2023)